Freedom Capital issued rating reports on Amgen stock, which trades on the NASDAQ exchange.
6 reports, 1 independent
Updated Fri 00:00
Mostly repetition
- Reports
- 6
- Developments
- 1
- Repetition
- 83%
New informationRepeats or wire copies
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
Freedom Capital issued rating reports on Amgen stock, which trades on the NASDAQ exchange.
Who's involved
What this event is mainly aboutKeep exploring
The entities involved
-
Amgen
American multinational biopharmaceutical company
-
Freedom Capital
company in the Czech Republic
-
Nasdaq
American fully electronic stock exchange
Related events
- Cantor Fitzgerald and other analyst firms issued ratings on Amgen stock, which is listed on the Nasdaq exchange.
- Amgen Inc. trades on the NASDAQ stock exchange.
- The market is reacting to the news of Novartis' drug trial failures, specifically impacting Amgen's stock performance on the Nasdaq exchange.
- Stock of Professional Diversity Network, Inc. traded on the Nasdaq exchange and was reported by MarketBeat.
- Avax One Technology Ltd. stock is traded on the Nasdaq exchange, and MarketBeat reports analyst ratings for the company.